Literature DB >> 11394738

Design of new selective inhibitors of cyclooxygenase-2 by dynamic assembly of molecular building blocks.

J Zhu1, H Yu, H Fan, H Liu, Y Shi.   

Abstract

A method of dynamically assembling molecular building blocks - DycoBlock - has been proposed and tested by Liu et al. This method is based on multiple-copy stochastic dynamics simulation in the presence of a receptor molecule. In this method, a novel algorithm was used to dynamically assemble the molecular building blocks to form candidate compounds. Currently, some new improvements have been incorporated into DycoBlock to make it more efficient. In the new version of DycoBlock, the binding energy and solvent accessible surface area (SASA) can be used to screen the resulting compounds. A simple clustering algorithm based on molecular similarity was developed and used to classify the remaining compounds. The revised DycoBlock was tested by breaking SC-558 - a selective inhibitor of cyclooxygenase-2 (COX-2) - into building blocks and reassembling them in the active site of the enzyme. The accuracy of recovery grew to 58.8% while it was only 16.7% in the previous version. Then, thirty-three kinds of molecular building blocks were used in the design of novel inhibitors and the investigation of diversity. As a result, a total of 1441 compounds was generated with high diversity. After the first screening procedure, there remained 864 reasonable compounds. The results from clustering indicate that the structural motifs in the diarylheterocycle class of COX-2-selective inhibitors have been generated using the revised DycoBlock, and their binding modes were investigated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11394738     DOI: 10.1023/a:1011114307711

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  15 in total

1.  Structure-based ligand design by dynamically assembling molecular building blocks at binding site.

Authors:  H Liu; Z Duan; Q Luo; Y Shi
Journal:  Proteins       Date:  1999-09-01

2.  The computer program LUDI: a new method for the de novo design of enzyme inhibitors.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

3.  Functionality maps of binding sites: a multiple copy simultaneous search method.

Authors:  A Miranker; M Karplus
Journal:  Proteins       Date:  1991

4.  CONCERTS: dynamic connection of fragments as an approach to de novo ligand design.

Authors:  D A Pearlman; M A Murcko
Journal:  J Med Chem       Date:  1996-04-12       Impact factor: 7.446

5.  The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases.

Authors:  D L DeWitt; E A el-Harith; S A Kraemer; M J Andrews; E F Yao; R L Armstrong; W L Smith
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

6.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.

Authors:  R G Kurumbail; A M Stevens; J K Gierse; J J McDonald; R A Stegeman; J Y Pak; D Gildehaus; J M Miyashiro; T D Penning; K Seibert; P C Isakson; W C Stallings
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

7.  HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site.

Authors:  M B Eisen; D C Wiley; M Karplus; R E Hubbard
Journal:  Proteins       Date:  1994-07

8.  Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.

Authors:  A S Kalgutkar; K R Kozak; B C Crews; G P Hochgesang; L J Marnett
Journal:  J Med Chem       Date:  1998-11-19       Impact factor: 7.446

9.  Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

Authors:  K Seibert; Y Zhang; K Leahy; S Hauser; J Masferrer; W Perkins; L Lee; P Isakson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Authors:  J L Masferrer; B S Zweifel; P T Manning; S D Hauser; K M Leahy; W G Smith; P C Isakson; K Seibert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

View more
  2 in total

1.  Structure-based ligand design for flexible proteins: application of new F-DycoBlock.

Authors:  J Zhu; H Fan; H Liu; Y Shi
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

Review 2.  Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.

Authors:  Varnavas D Mouchlis; Antreas Afantitis; Angela Serra; Michele Fratello; Anastasios G Papadiamantis; Vassilis Aidinis; Iseult Lynch; Dario Greco; Georgia Melagraki
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.